Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.

This study has been completed.

Study NCT00553449 Information provided by Janssen-Ortho Inc., Canada

First Received: November 1, 2007 Last Updated: May 16, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2005
Estimated Primary Completion Date:	No date given